Episode 88 | Cannabis and Driving – with Dr. Tom Marcotte

We talk about acute effects of cannabis use (THC) on driving performance with Tom Marcotte, a clinical scientist with decades of experience in this area. We cover the acute cognitive effects of cannabis, the time course of the effects of cannabis on driving performance (based on a driving simulator), the relationship between subjective perceptions of driving performance and actual performance, relevant legal and legislative issues related to cannabis and driving, and differences between recreational and medicinal cannabis on cognition and driving.

Episode 82 | Neuropsychological Norms for Spanish Speaking People in the U.S. – With Dr. Maria Marquine

This episode is a conversation about neuropsychological norms for Spanish speaking people who reside in the U.S. It focuses on the NP-NUMBRS project, which provides norms for a multidomain cognitive battery completed by Spanish speakers from the U.S.-Mexico border region. Additional topics covered include shared aspects of Hispanic/Latinx culture that are relevant to neuropsychologists, the importance of co-normed cognitive batteries in neuropsychology, and cognitive effects of bilingualism, among others.

Episode 20 | The Interplay Between Cerebrovascular Disease and Alzheimer’s Disease – With Dr. Adam Brickman

Adam Brickman, Ph.D., returns to discuss the involvement of white matter disease in Alzheimer’s disease progression and clinical presentation. Dr. Brickman discusses his research on the presence of biomarkers of cerebrovascular disease (e.g., white matter hyperintensities), which are present in aging and Alzheimer’s disease. Although cerebrovascular disease is traditionally associated with its own unique cognitive profile, Dr. Brickman discusses evidence suggesting that the cognitive deficits and underlying etiologies often commingle and complicate our case conceptualization. Additionally, he proposes the integral role that cerebrovascular disease may play in predicting (and possibly initiating) disease progression and cognitive decline in Alzheimer’s disease.